Project cooperationUpdated on 21 January 2026
PRE-CLINICAL Industrial/academic partner search
Grants Officer at Axxam SPA
Milano, Italy
About
A developing consortium, under the Call HLTH-2026-01-TOOL-03, is seeking one additional EU- or UK-based partner (SME, industry, or academic institution), preferably non-Italian, that owns at least one small-molecule preclinical oncology candidate (ideally in immuno-oncology) to be advanced towards clinical phases and is willing to collaborate in the design, development, validation, and regulatory assessment of cutting-edge NAMs
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Type
- Consortium/Coordinator seeks Partners
Organisation
Similar opportunities
Project cooperation
Luminescent dyes for advanced diagnosis
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Fabio Rizzo
Associate Professor at University of Milan
Milano, Italy
Project cooperation
Advancing Single-Molecule De-Novo Protein Sequencing
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Til Schlotter
ETH Researcher, Co-founder & CEO at UNOMR AG
Zurich, Switzerland
Project cooperation
Seeking collaboration in ATMP and New Approach Methodologies
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
Grzegorz Chodaczek
Immunotherapy Group Leader at Łukasiewicz Research Network - PORT Polish Center for Technology Development
Wrocław, Poland